Zotiraciclib | m-entrepreneurship.com

Product Name :
Zotiraciclib

Search keywords :
Zotiraciclib

drugId :
null

Target Vo:
Cyclin-dependent kinase 1

Target Vo Short Name :
CDK1

Moa_Name:
Cyclin-dependent kinase 9 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Syncore Biotechnology Co Ltd

Active Company_Name :
Cothera Bioscience Hong Kong Ltd

Active Indication_Name:
Glioblastoma

In Active Indication_Name:
Carcinoma, Hepatocellular

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PKC beta 2 Antibody
AMPK beta 1 Antibody
TRAF2 Antibody: TRAF2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to TRAF2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts